title: Somatic genetic analysis of cyclic AMP action: characterization of unresponsive mutants.
abstract: N-6,O-2'-dibutyryl adenosine 3',5'-monophosphate kills cultured mouse lymphosarcoma cells, but not resistant mutants derived by a single-step clonal selection. Resistant clones lack the cyclic AMP binding proteins present in wild type, cyclic AMP sensitive clones. Both endogenous cyclic AMP, accumulated in response to isoproterenol or cholera toxin, and exogenous dibutyryl cyclic AMP induce cyclic AMP phosphodiesterase, slow growth, and eventually kill wild type cells. In the resistant mutants, however, the endogenous and exogenous cyclic nucleotides appear to be completely inactive. These results indicate that an intracellular receptor for cyclic AMP, previously shown to be associated with a cyclic AMP-dependent protein kinase, mediates cyclic AMP's regulation of growth and phosphodiesterase synthesis.
mesh_terms: D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000096:biosynthesis; D003994:Bucladesine / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism / Q000502:physiology*; D004351:Drug Resistance; D007545:Isoproterenol / Q000494:pharmacology; D008223:Lymphoma / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D008967:Molecular Biology; D009154:Mutation; D011458:Prostaglandins E / Q000494:pharmacology; D012641:Selection, Genetic; D013347:Subcellular Fractions / Q000378:metabolism
chemical_list: D011458:Prostaglandins E; D003994:Bucladesine; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D007545:Isoproterenol